Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Investor profile

Venrock

Venture capital firm · Founded 1969 · Active in 2026

Venrock is a venture capital firm based in USA, founded in 1969. The page below shows 94 Power Law outcomes from Venrock's portfolio — 72 unicorns ($1B+ valuation) and 4 additional thoroughbreds (companies that crossed $100M+ in revenue without yet reaching $1B+ valuation).

Outcomes are concentrated in Biotech & Life Sciences · Cybersecurity · Health Tech & Medtech; top portfolio geographies are USA · Denmark · Germany. Venrock ranks #56 in Global in the 2026 Dealroom Power Law Investor Ranking by cross-stage outcomes.

94 Power Law outcomes Power Law Ranking #56 · Global · 94 Power Law outcomes · Active 2026
Unicorns ↑ 36% 5y
72
Decacorns ↓ 11% 5y
8
Thoroughbreds ↑ 30% 5y
45
01 · Exits

Sequoia’s biggest exits.

Sequoia portfolio companies worth $1B+ that have IPO’d or been acquired. Each shows its valuation at exit and, in grey, its current value if still public.

IPO · 1999
Entered SeedNow $5.2T
IPO · 2004
Entered Series ANow $4.6T
IPO · 1980
Now $4.5T
IPO · 2014
Entered Series B+Now $306B
$214B IPO · 2021
Entered Series B+Now $20.1B
IPO · 2012
Entered Series ANow $207B
$82.0B IPO · 2019
Now $153B
IPO · 2012
Entered Series B+Now $103B
$95.0B IPO · 2020
Entered SeedNow $69.1B
$93.9B IPO · 2020
Entered Series B+Now $58.4B
$24.0B IPO · 2018
Entered Series B+Now $73.3B
$39.0B IPO · 2020
Entered Series ANow $67.6B
$32.0B IPO · 2021
Entered Series B+Now $67.5B
$41.5B IPO · 2021
Entered SeedNow $64.4B
$60.0B IPO · 2021
Entered Series B+Now $28.0B
$55.5B IPO · 2026
Entered Series B+Now $55.5B
$52.8B IPO · 2018
Entered Series ANow $49.6B
IPO · 2013
Now $45.0B
IPO · 2015
Entered Series B+Now $39.4B
IPO · 2002
Entered SeedNow $39.1B
$32.0B acquisition · 2025
Entered Seed
$12.0B IPO · 2021
Entered Series B+Now $29.5B
IPO · 2014
Entered Series B+Now $28.6B
IPO · 2015
Entered Series ANow $28.2B
03 · Portfolio analysis

The 94 Venrock Power Law outcomes ($100M+ revenue or $1B+ valuation).

Snapshot of where the outcomes are concentrated by country, sector, and stage entered.

By countryCount
  1. USA83
  2. Denmark2
  3. Germany2
  4. Ireland1
  5. Netherlands1
  6. Mexico1
  7. Canada1
  8. China1
  9. UK1
  10. Israel1
By sectorCount
  1. Biotech & Life Sciences54
  2. Cybersecurity8
  3. Health Tech & Medtech7
  4. Other6
  5. Other B2B Software5
  6. Marketing5
  7. Transportation3
  8. Fintech3
  9. Space2
  10. Energy1
By stage enteredCount
  1. Series B+43
  2. Series A29
  3. Seed4
Estimated holdings

Venrock’s biggest current holdings.

An estimate of Venrock’s largest live positions — disclosed shareholding × Dealroom’s latest valuation — across 10 companies where Venrock is a named shareholder, worth about $4.1B in estimated equity value.

#CompanyEst. stakeValuationEst. value
  1. 1 Devoted HealthHealth · Decacorn 7% $12.9B $903M
  2. 2 AledadeHealth · Unicorn 18.5% $3.5B $648M
  3. 3 Lyra HealthEnterprise Software · Unicorn 11% $5.8B $644M
  4. 4 6SenseEnterprise Software · Unicorn 11.5% $5.2B $598M
  5. 5 ABL Space SystemsSpace · Unicorn 11.5% $2.4B $276M
  6. 6 DataminrSecurity · Unicorn 6.5% $4.1B $266M
  7. 7 13.5% $1.9B $256M
  8. 8 11% $2.0B $220M
  9. 9 13.5% $1.0B $135M
  10. 10 4% $2.8B $112M

4 companies hidden on this public profile. Estimated value = Venrock’s disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. Venrock also appears inside investor groups in Dapper Labs, where a standalone stake isn’t disclosed. See the underlying cap tables on Dealroom →

Venrock’s biggest exits.

Venrock portfolio companies worth $1B+ that have IPO’d or been acquired. Each shows its valuation at exit and, in grey, its current value if still public.

IPO · 1980
Now $4.5T
$89.9B IPO · 2021
Entered Series ANow $4.8B
$4.4B IPO · 2019
Entered Series ANow $75.8B
IPO · 2000
Entered Series ANow $23.2B
IPO · 2007
Entered Series ANow $20.0B
IPO · 2015
Entered Series B+Now $15.6B
Neurocrine Biosciences
IPO · 1996
Now $14.8B
IPO · 1996
Entered Series ANow $12.9B
$457M IPO · 2019
Entered Series B+Now $12.6B
IPO · 2013
Entered Series B+Now $10.9B
IPO · 2015
Entered Series B+Now $9.2B
IPO · 2014
Entered Series ANow $9.0B
$191M IPO · 2021
Entered Series B+Now $6.8B
$94M IPO · 2017
Now $6.7B
$1.9B IPO · 2021
Entered Series ANow $6.0B
$130M IPO · 2016
Entered Series B+Now $5.6B
IPO · 2010
Entered Series B+Now $5.2B
$1.1B IPO · 2023
Now $5.1B
$350M IPO · 2018
Entered Series B+Now $5.0B
$4.9B IPO · 2025
Entered Series B+Now $4.9B
$4.1B IPO · 2023
Entered Series B+Now $3.7B
$3.7B IPO · 2019
Entered Series B+Now $2.5B
IPO · 2023
Now $3.6B
IPO · 2011
Entered Series B+Now $3.6B

+31 more $1B+ exits on the full Dealroom profile.

04 · Portfolio market map

Venrock's 94 Power Law outcomes.

Stage entered
Outcome tier
Region
Group by
94 of 94 Power Law outcomes
05 · Power Law comparison

How does Venrock stack up?

Venrock in orange, your selection in blue and other colours. Pick from the global roster of 609 peer investors — scope by startup location or hit "Find similar shapes" to auto-pick the three closest. The funnel matrix mirrors the spider chart on the ranking page; the line chart shows each firm's share of unicorns minted in the selected startup location — peaks reveal vintage years.

Compare against

Share of new unicorns per year

% of global unicorns minted that year, year by year · hover the chart to see which unicorns
Performance window All-time → 2026

Stage focus

Companies by selected outcome stage

Sector focus

Companies per investor across the 10 highest-volume sectors

Beyond Unicorns — how the portfolio compounds

% of each investor's unicorn portfolio that later crossed $10B, $25B and $50B. Pick a sort tier and entry stage.
Sort by
Entry stage
Source: Dealroom Power Law dataset. Investors shown are the 2026 Power Law top 35 by combined entry-to-outcome score, drawn from the overview and locations_data sheets. Funnel-matrix axes rescale per-axis using the maximum among the currently selected investors, so the polygons always fill the chart for shape comparison.
06 · Portfolio founders

Where Sequoia's portfolio founders come from — and where they studied.

148 founders across the 94 Power Law outcomes — split by country of origin, university attended, and the company they worked at before founding. Stanford University and Castlight Health are the deepest single pipelines.

LocationCount
United States101
United Kingdom7
Canada5
China4
India4
France3
Germany2
Iran2
Ukraine2
Finland2
+2 more →
UniversityCount
Stanford University13
Harvard University6
Berkeley6
Williams College4
University of Michigan3
University of Kentucky3
Massachusetts Institute of Technology3
University of Rochester3
Stanford University Graduate School of Business3
University of Cambridge2
+52 more →
Origin companyCount
Castlight Health4
Endeca4
Apple3
athenahealth3
Alphabet | Google3
Uber3
Stemcentrx2
Microsoft2
Five Prime Therapeutics2
Forward Pharma2
+40 more →
Origin = country a founder is born in or grew up in (founders may have multiple origins; counts include all entries). University = highest-listed degree. Origin company = a previous employer where the founder was tagged before starting their current company.
07 · Key people

Key people at Venrock.

Sources: Dealroom desktop research, official firm profiles and public investor lists.

Market sentiment

What the market is saying about Venrock

An AI-synthesized read of the highest-engagement posts about Venrock on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

In the news

Latest news about Venrock

Recent press, funding announcements, and portfolio moves mentioning Venrock — pulled live from Dealroom's news feed.

See all news

Want the full picture on Venrock?

The Dealroom platform tracks every round, every co-investor, and every portfolio company in real time — across 25,000+ investors and 3M+ companies globally.